๐ฐ Affera Mapping News
Affera Mapping News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Affera Mapping. Real-time updates on events, politics, business and more.
May 20, 2024
Medtronic's SPHERE Per-AF study results reveal the Sphere-9 Catheter's superior safety and efficacy in treating persistent atrial fibrillation compared to the Thermocool SmartTouch SF. The Sphere-9 offers advanced mapping and ablation, showing higher freedom from AFib and fewer complications.
May 18, 2024
Medtronic (NYSE: MDT) announced data showing the safety and efficacy of its Affera mapping and ablation system with the Sphere-9 catheter.
January 30, 2024
Dublin, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The
December 20, 2023
The company โ which is headquartered out of Fridley, Minnesota โ is set to bring treatment for atrial fibrillation to market next year
April 19, 2023
12-month results reinforce versatility and durability for the treatment of paroxysmal and persistent AFib with the first-of-its-kind pulsed field ablation, radiofrequency, and high density mapping Sphere-9 Catheterย
March 15, 2023
Medtronic announced today that it received CE mark approval for its Affera mapping and ablation system.